"By mapping the full genetic blueprint of the tumor, researchers hope the information will eventually lead to the development of more targeted drugs and a better understanding of which prostate cancers are likely to spread, one of the biggest challenges for physicians and patients."
http://www.businessweek.com/lifestyle/content/healthday/649762.html
Exciting news; if not for us, then our sons and grandsons. Hopefully this is a first step towards truly discerning indolent from aggressive prostate cancer.
No comments:
Post a Comment